Literature DB >> 6342327

The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency.

U Kuhnle, A Rösler, J A Pareira, P Gunzcler, L S Levine, M I New.   

Abstract

The effect of normalization of sodium balance was evaluated in children with aldosterone deficiency of several etiologies. In salt-losing congenital adrenal hyperplasia (CAH), treatment with a mineralocorticoid in doses that normalized plasma renin activity (PRA) induced a marked increase in linear growth. Serum 17-hydroxyprogesterone (17-OHP) and androgens fell further when adequate sodium balance was achieved, allowing in some cases a reduction in glucocorticoid replacement dose. Together with PRA measurement they were the most sensitive indicators of adequate mineralocorticoid and glucocorticoid replacement therapy. In 2 teenage children with aldosterone deficiency due to Addison's and autoimmune polyglandular disease similar improvement in growth as well as onset of puberty occurred when sodium balance was normalized by increased mineralocorticoid therapy. These studies show that adequate sodium balance is essential for normal growth and pubertal development.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342327     DOI: 10.1530/acta.0.1020577

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  5 in total

1.  Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.

Authors:  I N Silva; C E Kater; C F Cunha; M B Viana
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

2.  Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  C Krüger; K Höper; R Weissörtel; J Hensen; H G Dörr
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

3.  Severe hypoaldosteronism due to corticosterone methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studies.

Authors:  B P Hauffa; J Sólyom; E Gláz; C H Shackleton; G Wambach; P Vecsei; H Stolecke; J Homoki
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

4.  Growth and reproductive outcomes in congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2010-02-01

5.  Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.

Authors:  H J Van der Kamp; B J Otten; N Buitenweg; S M P F De Muinck Keizer-Schrama; W Oostdijk; M Jansen; H A Delemarre-de Waal; T Vulsma; J M Wit
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.